8-KOther EventsExhibits & Filings

METLIFE INC 8-K Report, Corporate Update (Aug 9, 2012)

Filed August 9, 2012For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife, Inc. announced on August 8, 2012, its successful issuance of $750 million in aggregate principal amount of 4.125% Senior Notes due 2042. This offering was conducted under MetLife's existing shelf registration statement and a related prospectus supplement, indicating efficient capital management and access to public debt markets. The issuance of these senior notes provides MetLife with additional long-term funding, which can be utilized for various corporate purposes, including general corporate uses, debt refinancing, or strategic initiatives. The fixed 4.125% interest rate on these notes, maturing in 2042, suggests a favorable borrowing cost for the company at the time of issuance, reflecting investor confidence in MetLife's financial stability.

Key Highlights

  • 1MetLife issued $750 million in Senior Notes due 2042.
  • 2The notes carry a fixed interest rate of 4.125%.
  • 3The offering was made under an existing shelf registration statement (Form S-3) and a prospectus supplement.
  • 4The issuance occurred on August 8, 2012, as detailed in an 8-K filing dated August 9, 2012.
  • 5Underwriting and pricing agreements were executed with Barclays Capital Inc., Citigroup Global Markets Inc., and UBS Securities LLC as representatives of the underwriters.
  • 6The notes are senior unsecured obligations of MetLife.

Frequently Asked Questions

The primary purpose of this 8-K filing was to report on MetLife's entry into an underwriting agreement and a pricing agreement for the sale of $750 million of its 4.125% Senior Notes due 2042.

Issuing senior notes allows MetLife to raise capital for various corporate needs, such as funding operations, refinancing existing debt, or pursuing strategic growth opportunities. It also diversifies the company's sources of funding and can strengthen its balance sheet.

A shelf registration statement (Form S-3 in this case) allows a company to pre-register securities it plans to sell over a period of time. This filing indicates that MetLife had already established the framework to issue debt, making the current offering a more streamlined process, as it only required a prospectus supplement to be filed for these specific notes.

The 4.125% interest rate represents the cost of borrowing for MetLife on these notes. A fixed rate provides certainty of interest expense. The rate itself is generally indicative of the market's perception of MetLife's creditworthiness and prevailing interest rate conditions at the time of issuance.